Med15 Inhibitors

Transcriptional regulators encompass a diverse group of chemical entities that influence gene expression at the transcriptional level. These compounds can act at various stages, including initiation, elongation, and termination of transcription as well as the post-transcriptional modification and processing of RNA transcripts. By modulating the activity of transcription factors, coactivators, histones, and kinases involved in transcription, these molecules can have a profound impact on the expression of genes. Compounds such as Triptolide and Flavopiridol target the fundamental process of transcription itself. Triptolide is known to exert its effects by inhibiting the activity of RNA polymerase II, which is essential for the transcription of mRNA. This inhibition can indirectly affect MED15 as it is part of the Mediator complex, which is crucial for RNA polymerase II-mediated transcription. Flavopiridol inhibits CDK9, a component of the positive transcription elongation factor b (P-TEFb), which is necessary for RNA polymerase II's transition from initiation to elongation. This action can reduce the efficiency of transcriptional regulation where MED15 plays a role. Another example is Cortistatin A, which targets the kinase module of the Mediator complex, altering the phosphorylation state of the carboxy-terminal domain (CTD) of RNA polymerase II and thus indirectly influencing MED15's function. Bromodomain inhibitors like JQ1 affect the recognition of acetylated lysines on histone tails, disrupting the recruitment of transcriptional regulators to chromatin and impacting the activity of MED15.